Articles

The EU process to classify titanium dioxide is at risk of being derailed by corporate lobbying.

The ISDS parallel justice system for big business is again and again used as a corporate weapon against the public interest. 10 recent cases from around the world show how the red carpet courts continue to thrive and reinforce injustice across the world.

Authoritarian right wing parties look set to do well at the upcoming European elections. But there is a huge gap between their 'anti-elite' rhetoric and the reality,

In preparation for the complicated process of hiring 27 new EU Commissioners, Corporate Europe Observatory presents an outline of the ideal profile of Commissioner candidates.

In Croatia, Italy and Romania communities have stopped dirty oil drilling, toxic mines and other disastrous corporate projects. Now, big business might get its way in ISDS corporate courts. But the local communities continue to stand strong.

Half of the expert group created by EFSA to work on the risks posed by gene drives have financial links to organisations developing this technology. Why did EFSA recruit such a problematic panel on such a sensitive issue?

Any future EU-UK trade agreement post-Brexit will have to deal with the financial sector. And the financial lobby has been pushing its own model for long. Their risky plans on 'regulatory cooperation' are uncovered in this report from Corporate Europe Observatory, LobbyControl, Observatoire des Multinationales and SpinWatch.

Big business has a new weapon to erode 'costly' protections for the environment, public health, workers and consumers: “good regulatory practices” in international trade agreements.

The pharmaceutical industry is one of the world’s most profitable, benefiting from a highly problematic model, which helps ensure many people still lack access to essential, life-saving medicines. While this has been a major issue in the global South for decades, the crisis engulfing affordable medicines is now also spreading in Europe.